Flavia F. Valente
Grande Abc, SP, Brazil
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications
Beyond traditional markers: integrating data mining to identify novel prognostic biomarkers in medullary thyroid carcinoma.
Journal: Virchows Archiv : an international journal of pathology
Published: April 21, 2026
RET 634 germline/gonadal mosaicism generating a second pathogenic amino acid change in multiple endocrine neoplasia type 2A.
Journal: American journal of medical genetics. Part A
Published: December 28, 2023
Genotype and phenotype landscape of MEN2 in 554 medullary thyroid cancer patients: the BrasMEN study.
Journal: Endocrine connections
Published: January 30, 2019
Retroposed copies of RET gene: a somatically acquired event in medullary thyroid carcinoma.
Journal: BMC medical genomics
Published: January 07, 2019
THE COMBINED USE OF CALCITONIN DOUBLING TIME AND 18F-FDG PET/CT IMPROVES PROGNOSTIC VALUES IN MEDULLARY THYROID CARCINOMA: THE CLINICAL UTILITY OF 18F-FDG PET/CT.
Journal: Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists
Published: June 15, 2017
Analysis of somatic mutations in BRAF, CDKN2A/p16 and PI3KCA in patients with medullary thyroid carcinoma.
Journal: Molecular medicine reports
Published: December 31, 2014
Integration of a postoperative calcitonin measurement into an anatomical staging system improves initial risk stratification in medullary thyroid cancer.
Journal: Clinical endocrinology
Published: July 04, 2014
A ten-year clinical update of a large RET p.Gly533Cys kindred with medullary thyroid carcinoma emphasizes the need for an individualized assessment of affected relatives.
Journal: Clinical endocrinology
Published: December 27, 2012
Showing 1-9 of 9
Last Updated: 09/26/2026